Kennedy Jr. returned to Capitol Hill Thursday, where he defended the administration’s efforts to fight health care fraud and ...

Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...

New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Readout ...

Scientists whose work led to powerful obesity drugs like Zepbound are now suggesting targeting the GLP-1 hormone is not ...

New research challenges what we know about GLP-1s, vaccine skepticism, and more health news from Morning Rounds ...

A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...

On Monday, Politico published a poll on vaccine attitudes titled, “More Americans doubt vaccine safety than trust it, ...

When health care infrastructure is attacked and held for ransom by hackers, patients become real casualties,” writes Andrea ...

Arbitration decisions, it turns out, are like cockroaches. They’re very hard to kill.

Schwartz's background as a physician with plenty of government service experience will likely be popular among lawmakers.

Kennedy Jr. has a delicate task ahead of him as he heads to Capitol Hill to testify about the fiscal 2027 budget request: ...

The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...